![Alice Chen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Alice Chen worked as the Executive Director-Clinical Operations at Skye Bioscience, Inc. from 2019 to 2020.
Prior to that, she was the Head-Clinical Operations at Zafgen, Inc. Ms. Chen received an undergraduate degree from the University of California San Diego.
Eerdere bekende functies van Alice Chen
Bedrijven | Functie | Einde |
---|---|---|
SKYE BIOSCIENCE, INC. | Hoofd Techniek/Wetenschap/O&O | 01-09-2020 |
LARIMAR THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Opleiding van Alice Chen
University of California San Diego | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SKYE BIOSCIENCE, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Zafgen, Inc.
![]() Zafgen, Inc. BiotechnologyHealth Technology Zafgen, Inc. is a biopharmaceutical company, which engages in the development of novel therapies for patients affected by complex metabolic diseases. It focuses on the study of MetAP2 inhibitors in both common and rare metabolic disorders. The firm also advancing programs for type 2 diabetes, Prader-Willi syndrome, and liver diseases. The company was founded on November 22, 2005 and is headquartered in Boston, MA. | Health Technology |